Cargando…

An evaluation of oxygen systems for treatment of childhood pneumonia

BACKGROUND: Oxygen therapy is recommended for all of the 1.5 – 2.7 million young children who consult health services with hypoxemic pneumonia each year, and the many more with other serious conditions. However, oxygen supplies are intermittent throughout the developing world. Although oxygen is wel...

Descripción completa

Detalles Bibliográficos
Autores principales: Catto, Alastair G, Zgaga, Lina, Theodoratou, Evropi, Huda, Tanvir, Nair, Harish, Arifeen, Shams El, Rudan, Igor, Duke, Trevor, Campbell, Harry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3231901/
https://www.ncbi.nlm.nih.gov/pubmed/21501446
http://dx.doi.org/10.1186/1471-2458-11-S3-S28
_version_ 1782218297119342592
author Catto, Alastair G
Zgaga, Lina
Theodoratou, Evropi
Huda, Tanvir
Nair, Harish
Arifeen, Shams El
Rudan, Igor
Duke, Trevor
Campbell, Harry
author_facet Catto, Alastair G
Zgaga, Lina
Theodoratou, Evropi
Huda, Tanvir
Nair, Harish
Arifeen, Shams El
Rudan, Igor
Duke, Trevor
Campbell, Harry
author_sort Catto, Alastair G
collection PubMed
description BACKGROUND: Oxygen therapy is recommended for all of the 1.5 – 2.7 million young children who consult health services with hypoxemic pneumonia each year, and the many more with other serious conditions. However, oxygen supplies are intermittent throughout the developing world. Although oxygen is well established as a treatment for hypoxemic pneumonia, quantitative evidence for its effect is lacking. This review aims to assess the utility of oxygen systems as a method for reducing childhood mortality from pneumonia. METHODS: Aiming to improve priority setting methods, The Child Health and Nutrition Research Initiative (CHNRI) has developed a common framework to score competing interventions into child health. That framework involves the assessment of 12 different criteria upon which interventions can be compared. This report follows the proposed framework, using a semi-systematic literature review and the results of a structured exercise gathering opinion from experts (leading basic scientists, international public health researchers, international policy makers and representatives of pharmaceutical companies), to assess and score each criterion as their “collective optimism” towards each, on a scale from 0 to 100%. RESULTS: A rough estimate from an analysis of the literature suggests that global strengthening of oxygen systems could save lives of up to 122,000 children from pneumonia annually. Following 12 CHNRI criteria, the experts expressed very high levels of optimism (over 80%) for answerability, low development cost and low product cost; high levels of optimism (60-80%) for low implementation cost, likelihood of efficacy, deliverability, acceptance to end users and health workers; and moderate levels of optimism (40-60%) for impact on equity, affordability and sustainability. The median estimate of potential effectiveness of oxygen systems to reduce the overall childhood pneumonia mortality was ~20% (interquartile range: 10-35%, min. 0%, max. 50%). However, problems with oxygen systems in terms of affordability, sustainability and impact on equity are noted in both expert opinion scores and on review. CONCLUSION: Oxygen systems are likely to be an effective intervention in combating childhood mortality from pneumonia. However, a number of gaps in the evidence base exist that should be addressed to complete the investment case and research addressing these issues merit greater funding attention.
format Online
Article
Text
id pubmed-3231901
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32319012011-12-07 An evaluation of oxygen systems for treatment of childhood pneumonia Catto, Alastair G Zgaga, Lina Theodoratou, Evropi Huda, Tanvir Nair, Harish Arifeen, Shams El Rudan, Igor Duke, Trevor Campbell, Harry BMC Public Health Research BACKGROUND: Oxygen therapy is recommended for all of the 1.5 – 2.7 million young children who consult health services with hypoxemic pneumonia each year, and the many more with other serious conditions. However, oxygen supplies are intermittent throughout the developing world. Although oxygen is well established as a treatment for hypoxemic pneumonia, quantitative evidence for its effect is lacking. This review aims to assess the utility of oxygen systems as a method for reducing childhood mortality from pneumonia. METHODS: Aiming to improve priority setting methods, The Child Health and Nutrition Research Initiative (CHNRI) has developed a common framework to score competing interventions into child health. That framework involves the assessment of 12 different criteria upon which interventions can be compared. This report follows the proposed framework, using a semi-systematic literature review and the results of a structured exercise gathering opinion from experts (leading basic scientists, international public health researchers, international policy makers and representatives of pharmaceutical companies), to assess and score each criterion as their “collective optimism” towards each, on a scale from 0 to 100%. RESULTS: A rough estimate from an analysis of the literature suggests that global strengthening of oxygen systems could save lives of up to 122,000 children from pneumonia annually. Following 12 CHNRI criteria, the experts expressed very high levels of optimism (over 80%) for answerability, low development cost and low product cost; high levels of optimism (60-80%) for low implementation cost, likelihood of efficacy, deliverability, acceptance to end users and health workers; and moderate levels of optimism (40-60%) for impact on equity, affordability and sustainability. The median estimate of potential effectiveness of oxygen systems to reduce the overall childhood pneumonia mortality was ~20% (interquartile range: 10-35%, min. 0%, max. 50%). However, problems with oxygen systems in terms of affordability, sustainability and impact on equity are noted in both expert opinion scores and on review. CONCLUSION: Oxygen systems are likely to be an effective intervention in combating childhood mortality from pneumonia. However, a number of gaps in the evidence base exist that should be addressed to complete the investment case and research addressing these issues merit greater funding attention. BioMed Central 2011-04-13 /pmc/articles/PMC3231901/ /pubmed/21501446 http://dx.doi.org/10.1186/1471-2458-11-S3-S28 Text en Copyright ©2011 Catto et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Catto, Alastair G
Zgaga, Lina
Theodoratou, Evropi
Huda, Tanvir
Nair, Harish
Arifeen, Shams El
Rudan, Igor
Duke, Trevor
Campbell, Harry
An evaluation of oxygen systems for treatment of childhood pneumonia
title An evaluation of oxygen systems for treatment of childhood pneumonia
title_full An evaluation of oxygen systems for treatment of childhood pneumonia
title_fullStr An evaluation of oxygen systems for treatment of childhood pneumonia
title_full_unstemmed An evaluation of oxygen systems for treatment of childhood pneumonia
title_short An evaluation of oxygen systems for treatment of childhood pneumonia
title_sort evaluation of oxygen systems for treatment of childhood pneumonia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3231901/
https://www.ncbi.nlm.nih.gov/pubmed/21501446
http://dx.doi.org/10.1186/1471-2458-11-S3-S28
work_keys_str_mv AT cattoalastairg anevaluationofoxygensystemsfortreatmentofchildhoodpneumonia
AT zgagalina anevaluationofoxygensystemsfortreatmentofchildhoodpneumonia
AT theodoratouevropi anevaluationofoxygensystemsfortreatmentofchildhoodpneumonia
AT hudatanvir anevaluationofoxygensystemsfortreatmentofchildhoodpneumonia
AT nairharish anevaluationofoxygensystemsfortreatmentofchildhoodpneumonia
AT arifeenshamsel anevaluationofoxygensystemsfortreatmentofchildhoodpneumonia
AT rudanigor anevaluationofoxygensystemsfortreatmentofchildhoodpneumonia
AT duketrevor anevaluationofoxygensystemsfortreatmentofchildhoodpneumonia
AT campbellharry anevaluationofoxygensystemsfortreatmentofchildhoodpneumonia
AT cattoalastairg evaluationofoxygensystemsfortreatmentofchildhoodpneumonia
AT zgagalina evaluationofoxygensystemsfortreatmentofchildhoodpneumonia
AT theodoratouevropi evaluationofoxygensystemsfortreatmentofchildhoodpneumonia
AT hudatanvir evaluationofoxygensystemsfortreatmentofchildhoodpneumonia
AT nairharish evaluationofoxygensystemsfortreatmentofchildhoodpneumonia
AT arifeenshamsel evaluationofoxygensystemsfortreatmentofchildhoodpneumonia
AT rudanigor evaluationofoxygensystemsfortreatmentofchildhoodpneumonia
AT duketrevor evaluationofoxygensystemsfortreatmentofchildhoodpneumonia
AT campbellharry evaluationofoxygensystemsfortreatmentofchildhoodpneumonia